Association of LAPTM4B gene polymorphism with breast cancer susceptibility

被引:27
|
作者
Fan, Meirong [1 ]
Liu, Ye [1 ]
Zhou, Rouli [2 ]
Zhang, Qingyun [1 ]
机构
[1] Peking Univ, Dept Clin Lab, Beijing Canc Hosp & Inst, Minist Educ,Sch Oncol,Key Lab Carcinogenesis & Tr, Beijing 100142, Peoples R China
[2] Peking Univ, Dept Cell Biol, Sch Basic Med Sci, Beijing 100142, Peoples R China
基金
中国国家自然科学基金;
关键词
Breast cancer; LAPTM4B; Polymorphism; Susceptibility; INDEPENDENT PROGNOSTIC MARKER; EXPRESSION; OVEREXPRESSION; PROGRESSION; RESISTANCE;
D O I
10.1016/j.canep.2011.12.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Lysosome associated protein transmembrane 4 beta (LAPTM4B) was a cancer-associated gene that is mapped to chromosome 8q22 with seven exons and six introns. LAPTM4B gene polymorphism has been reported to be significantly associated with susceptibility of several solid tumors. Methods: We performed a case-control study was to investigate the association between LAPTM4B polymorphism and the risk of breast cancer in 732 breast cancer patients and 649 controls. Results: A significant difference in the frequency of LAPTM4B*2 was observed between the patients and the controls (P < 0.01). Using the LAPTM4B*1/1 genotype as a reference, we found that LAPTM4B allelic variation was significantly associated with breast cancer occurrence, with adjusted odds ratios of 1.387 (95% CI = 1.111-1.730) for LAPTM4B*1/2 and 1.592 (95% CI = 1.043-2.430) for LAPTM4B*2/2 genotype. Conclusion: Our results suggested that LAPTM4B* 2 is associated with an increased risk of breast cancer in the Chinese women population and may be a risk factor of breast cancer. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:364 / 368
页数:5
相关论文
共 50 条
  • [21] Correlation of LAPTM4B polymorphisms with gallbladder carcinoma susceptibility in Chinese patients
    Yang, Hua
    Zhai, Guojun
    Ji, Xiaoxu
    Xiong, Fuxia
    Su, Jing
    McNutt, Michael A.
    MEDICAL ONCOLOGY, 2012, 29 (04) : 2809 - 2813
  • [22] Serum LAPTM4B as a Potential Diagnostic and Prognostic Biomarker for Breast Cancer
    Wang, Lu
    Wang, Yating
    Zhang, Qingyun
    BIOMED RESEARCH INTERNATIONAL, 2022, 2022
  • [23] Correlation of LAPTM4B polymorphisms with hepatocellular carcinoma in Chinese patients
    Zhai, Guojun
    Yang, Hua
    Ji, Xiaoxu
    Xiong, Fuxia
    Su, Jing
    McNutt, Michael A.
    Li, Xuan
    MEDICAL ONCOLOGY, 2012, 29 (04) : 2744 - 2749
  • [24] LAPTM4B promotes the progression of nasopharyngeal cancer
    Su, Qun
    Luo, Hongtao
    Zhang, Ming
    Gao, Liying
    Zhao, Fengju
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 21 (03) : 305 - 312
  • [25] Overexpression of LAPTM4B: an independent prognostic marker in breast cancer
    Min Xiao
    Shusheng Jia
    Hongbin Wang
    Jinsong Wang
    Yuanxi Huang
    Zhigao Li
    Journal of Cancer Research and Clinical Oncology, 2013, 139 : 661 - 667
  • [26] LAPTM4B gene polymorphism augments the risk of cancer: Evidence from an updated meta-analysis
    Hashemi, Mohammad
    Bahari, Gholamreza
    Tabasi, Farhad
    Markowski, Jaroslaw
    Malecki, Andrzej
    Ghavami, Saeid
    Los, Marek J.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 22 (12) : 6396 - 6400
  • [27] LAPTM4B polymorphism increases susceptibility to multiple cancers in Chinese populations: a meta-analysis
    Cuiju Mo
    Yu Lu
    Yan Deng
    Jian Wang
    Li Xie
    Taijie Li
    Yu He
    Qiliu Peng
    Xue Qin
    Shan Li
    BMC Genetics, 15
  • [28] LAPTM4B Allele*2 Is a Marker of Poor Prognosis for Gallbladder Carcinoma
    Zhai, Guojun
    Yan, Kaowen
    Ji, Xiaoxu
    Xu, Wenrui
    Yang, Jiuling
    Xiong, Fuxia
    Su, Jing
    McNutt, Michael A.
    Yang, Hua
    PLOS ONE, 2012, 7 (09):
  • [29] Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients
    Li, Sha
    Wang, Lu
    Meng, Yue
    Chang, Yanli
    Xu, Jianjun
    Zhang, Qingyun
    ONCOTARGET, 2017, 8 (25) : 41282 - 41293
  • [30] Correlation of LAPTM4B polymorphisms with gallbladder carcinoma susceptibility in Chinese patients
    Hua Yang
    Guojun Zhai
    Xiaoxu Ji
    Fuxia Xiong
    Jing Su
    Michael A. McNutt
    Medical Oncology, 2012, 29 : 2809 - 2813